Transcriptional regulation of the human μ opioid receptor (hMOR) gene: Evidence of positive and negative Cis-acting elements in the proximal promoter and presence of a distal promoter

DNA and Cell Biology

Volumn 20, Issue 7, 2001, Pages 391-402

  Xu, Y ^a   Carr, L G ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; MORPHINE; MU OPIATE RECEPTOR;

5' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG BINDING SITE; DRUG DEPENDENCE; GENE CONTROL; GENE EXPRESSION; GENE LOCATION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; METHYLATION; NEUROBLASTOMA CELL; PAIN; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION;

BINDING SITES; DNA FOOTPRINTING; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; PROMOTER REGIONS (GENETICS); RECEPTORS, OPIOID, MU; REGULATORY SEQUENCES, NUCLEIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SP1 TRANSCRIPTION FACTOR; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0034819931     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454901750361451     Document Type: Article

References (44)

1. Localization of promoter elements in the human mu-opioid receptor gene and regulation by DNA methylation
2. Effect of chronic cocaine treatment on mu- and delta-opioid receptor mRNA levels in dopaminergically innervated brain regions
3. Association of tran-scriptionally silent genes with Ikaros complexes at centromeric het-erochromatin
4. Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment
5. Mouse mu opi-oid receptor gene expression: A 34-base pair cis-acting element inhibits transcription of the mu opioid receptor gene from the distal promoter
6. Regulation of mu-opioid receptor mRNA in rat globus pallidus: Effects of enkephalin increases induced by short-and long-term haloperidol administration
7. In vivo regulation of mu-opioid receptor density and gene expression in CXBK and out-bred Swiss Webster mice
8. Identification and characterization of negative regulatory elements of the human telomerase catalytic subunit (hTERT) gene promoter: Possible role of MZF-2 in transcriptional repression of hTERT
9. Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment
10. Tissue-specific in vitro transcription from the mouse albumin promoter
11. A new technique for the assay of infectivity of human adenovirus 5 DNA
12. Competition between transcription factors HNF1 and HNF3, and alternative cell-specific activation by DBP and C/EBP contribute to the regulation of the liver-specific aldolase B promoter
13. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL
14. Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells
15. Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes
16. Dual promoters of mouse mu-opioid receptor gene
17. Ikaros interactions with CtBP reveal a repression mechanism that is independent of hi-stone deacetylase activity
18. Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes
19. Sequence-specific recognition of DNA by zinc-finger peptides derived from the transcription factor Sp1
20. Transcriptional regulation of the apolipoprotein A-IV gene involves synergism between a proximal orphan receptor response element and a distant enhancer located in the upstream promoter region of the apolipoprotein C-III gene
21. Molecular mechanisms and regulation of opioid receptor signaling
22. Mu opioid receptor knockout in mice: Effects on ligand-induced analgesia and morphine lethality
23. Molecular characterization of opioid receptors
24. Mu-opioid receptor mRNA expression in the rat CNS: Comparison to mu-receptor binding
25. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene
26. Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cells
27. Molecular cloning and in situ hybridization histochem-istry for rat mu-opioid receptor
28. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins
29. CCAAT/enhancer-binding proteins alpha and beta interact with the silencer element in the promoter of glutathione S-transferase P gene during hepatocarcino-genesis
30. MatInd and MatInspector: New fast and versatile tools for detection of consensus matches in nucleotide sequence data
31. The myeloid zinc finger gene (MZF-1) delays retinoic acid-induced apoptosis and differentiation in myeloid leukemia cells
32. Downregu-lation of mu-opioid receptor mRNA in the mediobasal hypothalamus of the female guinea pig following morphine treatment
33. The interleukin-1beta-medi-ated regulation of proenkephalin and opioid receptor messenger RNA in primary astrocyte-enriched cultures
34. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase
35. Rapid detection of octamer binding proteins with "mini-extracts" prepared from a small number of cells
36. In vivo homologous regulation of mu-opioid receptor gene expression in the mouse
37. A high-efficiency HeLa cell nuclear transcription extract
38. Structure and regulation of the senescence marker protein 2 gene promoter
39. CCAAT displacement protein (CDP/cut) binds a negative regulatory element in the human tryptophan hydroxylase gene
40. The mu opiate receptor as a candidate gene for pain: Polymorphisms, variations in expression, nociception, and opiate responses
41. Effect of ethanol drinking on the gene expression of opioid receptors, enkephalinase, and angiotensin-converting enzyme in two inbred mice strains
42. Functional chararcterization of the promoter region of the human mu opioid receptor (hMOR) gene: Identification of activating and inhibitory regions
43. A human neu-roblastoma cell line expresses mu and delta opioid receptor sites
44. Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse